#BEGIN_DRUGCARD DB02225

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C18H36NO6PS2

# Chemical_IUPAC_Name:
[(6S,9R)-2,2-dimethyl-9,10-bis(pentanoyloxy)-6-sulfanylidene-5,7-dioxa-2-aza-6$l^{5}-phosphadecan-2-ium-6-yl]sulfanide

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
1,2-Di-N-Pentanoyl-Sn-Glycero-3-Dithiophosphocholine

# HET_ID:
PC5

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C18H36NO6PS2/c1-6-8-10-17(20)22-14-16(25-18(21)11-9-7-2)15-24-26(27,28)23-13-12-19(3,4)5/h16H,6-15H2,1-5H3/t16-/m1/s1

# InChI_Key:
InChIKey=WEXRBKRFCBLWEL-MRXNPFEDSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2225

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
457.585

# Molecular_Weight_Mono:
457.172165781

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1P6E

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.58

# Predicted_LogS:
-6.5

# Predicted_Water_Solubility:
1.75e-04 g/l

# Primary_Accession_No:
DB02225

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
447776

# PubChem_Substance_ID:
46505514

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02514

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCCCC(=O)OC[C@H](CO[P@@]([S-])(=S)OCC[N+](C)(C)C)OC(=O)CCCC

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:55 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X64141

# Drug_Target_1_GenBank_ID_Protein:
312906

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
plc

# Drug_Target_1_Gene_Sequence:
>852 bp
ATGAAAAAGAAAGTACTTGCTTTAGCAGCAGCTATTACAGTAGTAGCTCCTTTACAAAGC
GTTGCATTTGCTCATGAAAATGATGGGGGAAGTAAAATAAAAATAGTTCACCGCTGGTCT
GCTGAAGATAAACATAAAGAAGGTGTAAATTCTCATTTATGGATTGTAAACCGTGCGATT
GATATTATGTCTCGCAATACAACACTTGTAAAACAAGATCGAGTTGCACAATTAAATGAA
TGGCGTACGGAGTTAGAGAACGGTATTTATGCTGCTGACTATGAAAATCCTTATTATGAT
AATAGCACATTTGCTTCACATTTCTATGATCCAGACAATGGAAAAACATATATTCCATTT
GCAAAGCAGGCAAAAGAAACTGGCGCTAAATATTTTAAATTAGCTGGTGAATCATACAAA
AATAAAGATATGAAACAAGCATTCTTCTATTTAGGATTATCTCTTCATTATTTAGGAGAT
GTAAACCAACCGATGCATGCGGCAAACTTTACAAATCTTTCATATCCACAAGGATTCCAT
TCTAAATATGAAAACTTTGTAGATACGATAAAAGATAATTATAAAGTAACGGATGGAAAT
GGATATTGGAACTGGAAAGGTACAAATCCAGAAGAGTGGATTCATGGAGCGGCAGTAGTA
GCGAAACAAGATTACTCTGGAATTGTAAATGATAATACGAAAGATTGGTTCGTAAAAGCA
GCTGTGTCACAAGAATATGCAGATAAATGGCGCGCTGAAGTTACACCAATGACAGGTAAG
CGATTAATGGATGCACAACGTGTTACTGCTGGATACATTCAGCTTTGGTTTGATACGTAC
GGAGATCGTTAA

# Drug_Target_1_General_Function:
Involved in hydrolase activity, acting on ester bonds

# Drug_Target_1_General_References:
1939031	Ikeda K, Inoue S, Amasaki C, Teshima K, Ikezawa H: Kinetics of the hydrolysis of monodispersed and micellar phosphatidylcholines catalyzed by a phospholipase C from Bacillus cereus. J Biochem (Tokyo). 1991 Jul;110(1):88-95.
2493587	Hough E, Hansen LK, Birknes B, Jynge K, Hansen S, Hordvik A, Little C, Dodson E, Derewenda Z: High-resolution (1.5 A) crystal structure of phospholipase C from Bacillus cereus. Nature. 1989 Mar 23;338(6213):357-60.
2841128	Yamada A, Tsukagoshi N, Udaka S, Sasaki T, Makino S, Nakamura S, Little C, Tomita M, Ikezawa H: Nucleotide sequence and expression in Escherichia coli of the gene coding for sphingomyelinase of Bacillus cereus. Eur J Biochem. 1988 Aug 1;175(2):213-20.
3137122	Johansen T, Holm T, Guddal PH, Sletten K, Haugli FB, Little C: Cloning and sequencing of the gene encoding the phosphatidylcholine-preferring phospholipase C of Bacillus cereus. Gene. 1988 May 30;65(2):293-304.
72664	Otnaess AB, Little C, Sletten K, Wallin R, Johnsen S, Flengsrud R, Prydz H: Some characteristics of phospholipase C from Bacillus cereus. Eur J Biochem. 1977 Oct 3;79(2):459-68.
8387306	Gavrilenko IV, Baida GE, Karpov AV, Kuz'min NP: [Nucleotide sequence of phospholipase C and sphingomyelinase genes from Bacillus cereus BKM-B164] Bioorg Khim. 1993 Jan;19(1):133-8.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2841

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
32383

# Drug_Target_1_Name:
Phospholipase C

# Drug_Target_1_Number_of_Residues:
283

# Drug_Target_1_PDB_ID:
1AH7

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00882	Zn_dep_PLPC

# Drug_Target_1_Protein_Sequence:
>Phospholipase C precursor
MKKKVLALAAAITVVAPLQSVAFAHENDGGSKIKIVHRWSAEDKHKEGVNSHLWIVNRAI
DIMSRNTTLVKQDRVAQLNEWRTELENGIYAADYENPYYDNSTFASHFYDPDNGKTYIPF
AKQAKETGAKYFKLAGESYKNKDMKQAFFYLGLSLHYLGDVNQPMHAANFTNLSYPQGFH
SKYENFVDTIKDNYKVTDGNGYWNWKGTNPEEWIHGAAVVAKQDYSGIVNDNTKDWFVKA
AVSQEYADKWRAEVTPMTGKRLMDAQRVTAGYIQLWFDTYGDR

# Drug_Target_1_Reaction:
a phosphatidylcholine + H2O = 1,2-diacylglycerol + choline phosphate

# Drug_Target_1_Signals:
1-24

# Drug_Target_1_Specific_Function:
Required, with sphingomyelinase, to effect target cell lysis (hemolysis)

# Drug_Target_1_SwissProt_ID:
P09598

# Drug_Target_1_SwissProt_Name:
PHLC_BACCE

# Drug_Target_1_Synonyms:
Cereolysin A
EC 3.1.4.3
PLC
Phosphatidylcholine cholinephosphohydrolase
Phospholipase C precursor

# Drug_Target_1_Theoretical_pI:
7.93

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02225
